The protective potential of Fc‐mediated antibody functions against influenza virus and other viral pathogens
HA Vanderven, SJ Kent - Immunology and cell biology, 2020 - Wiley Online Library
In recent years, there has been a renewed interest in utilizing antibody fragment
crystallizable (Fc) functions to prevent and control viral infections. The protective and …
crystallizable (Fc) functions to prevent and control viral infections. The protective and …
Immune responses in influenza A virus and human coronavirus infections: an ongoing battle between the virus and host
Highlights•Host immune responses play both protective and pathogenic roles in IAV and
CoV infections.•Synergy of adaptive and innate immunity is required for efficient control of …
CoV infections.•Synergy of adaptive and innate immunity is required for efficient control of …
Neuraminidase inhibition contributes to influenza A virus neutralization by anti-hemagglutinin stem antibodies
I Kosik, D Angeletti, JS Gibbs, M Angel… - Journal of Experimental …, 2019 - rupress.org
Broadly neutralizing antibodies (Abs) that bind the influenza virus hemagglutinin (HA) stem
may enable universal influenza vaccination. Here, we show that anti-stem Abs sterically …
may enable universal influenza vaccination. Here, we show that anti-stem Abs sterically …
Development of influenza B universal vaccine candidates using the “mosaic” hemagglutinin approach
Influenza B viruses cause seasonal epidemics and are a considerable burden to public
health. However, protection by current seasonal vaccines is suboptimal due to the antigenic …
health. However, protection by current seasonal vaccines is suboptimal due to the antigenic …
[HTML][HTML] Next generation of computationally optimized broadly reactive HA vaccines elicited cross-reactive immune responses and provided protection against H1N1 …
Vaccination is the best way to prevent influenza virus infections, but the diversity of
antigenically distinct isolates is a persistent challenge for vaccine development. In order to …
antigenically distinct isolates is a persistent challenge for vaccine development. In order to …
[HTML][HTML] Identification of a highly conserved neutralizing epitope within the RBD region of diverse SARS-CoV-2 variants
Y Wang, A Yan, D Song, M Duan, C Dong… - Nature …, 2024 - nature.com
The constant emergence of SARS-CoV-2 variants continues to impair the efficacy of existing
neutralizing antibodies, especially XBB. 1.5 and EG. 5, which showed exceptional immune …
neutralizing antibodies, especially XBB. 1.5 and EG. 5, which showed exceptional immune …
[HTML][HTML] A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus
Protective Ebola virus (EBOV) antibodies have neutralizing activity and induction of antibody
constant domain (Fc)-mediated innate immune effector functions. Efforts to enhance Fc …
constant domain (Fc)-mediated innate immune effector functions. Efforts to enhance Fc …
[HTML][HTML] Combined anti-S1 and anti-S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2
Antibodies capable of neutralizing SARS-CoV-2 are well studied, but Fc receptor–
dependent antibody activities that can also significantly impact the course of infection have …
dependent antibody activities that can also significantly impact the course of infection have …
[HTML][HTML] Adenoviral vectors as vaccines for emerging avian influenza viruses
LJ Kerstetter, S Buckley, CM Bliss… - Frontiers in …, 2021 - frontiersin.org
It is evident that the emergence of infectious diseases, which have the potential for spillover
from animal reservoirs, pose an ongoing threat to global health. Zoonotic transmission …
from animal reservoirs, pose an ongoing threat to global health. Zoonotic transmission …
[HTML][HTML] HER2-displaying M13 bacteriophages induce therapeutic immunity against breast cancer
Simple Summary The high incidence and death rates of breast cancer make the
development of new therapies an urgent need. The introduction into the clinic of the anti …
development of new therapies an urgent need. The introduction into the clinic of the anti …